Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
NCT01196884 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 190
Last updated 2018-03-20
Summary
Primary ITP has wide heterogenous biology, presentation and response to therapy.
The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.
Conditions
Sponsors & Collaborators
-
Azienda Sanitaria-Universitaria Integrata di Udine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
Countries
- Italy
Study Locations
More Related Trials
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe
NCT06408324 ·Status: COMPLETED
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia
NCT05468866 ·Status: UNKNOWN ·Phase: NA
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
Association of TNFAIP3 With Immune-mediated TTP
NCT06928233 ·Status: RECRUITING ·Phase: NA
-
This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
NCT02859909 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010
NCT06466824 ·Status: NOT_YET_RECRUITING
-
Risk Factors for Thrombosis in Immune Thrombocytopenia
NCT03820960 ·Status: COMPLETED
-
Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura
NCT04311593 ·Status: UNKNOWN
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura
NCT05093257 ·Status: UNKNOWN
-
Italian iTTP Registry
NCT06376786 ·Status: RECRUITING
-
Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP
NCT04735588 ·Status: UNKNOWN
-
Autoantibody Specificity and Response to IVIG in ITP
NCT01666795 ·Status: COMPLETED
-
Research of Predictive Factors to Immune Thrombopenic Purpura
NCT01648556 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
NCT06544499 ·Status: RECRUITING ·Phase: PHASE3
-
ITP Registry and Accompanying Biospecimen Collection
NCT05152238 ·Status: RECRUITING
-
The International ITP Registry
NCT01970189 ·Status: UNKNOWN
-
Lymphocyte Counts in Immune Thrombocytopenic Purpura
NCT03244410 ·Status: UNKNOWN
-
Immune Markers in Pediatric ITP on Second Line Therapy
NCT06093529 ·Status: NOT_YET_RECRUITING
-
Study of Immune Thrombocytopenia Pathogenesis:
NCT02042560 ·Status: COMPLETED